Viewing Study NCT05592756


Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2026-01-01 @ 12:17 PM
Study NCT ID: NCT05592756
Status: COMPLETED
Last Update Posted: 2023-06-13
First Post: 2022-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed
Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module